Get the Stockscreener App
20.46
2.04%
0.41
After Hours:
20.45
-0.01
-0.05%
Mediwound Ltd stock is traded at $20.46, with a volume of 77,898.
It is up +2.04% in the last 24 hours and up +5.30% over the past month.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
See More
Previous Close:
$20.05
Open:
$20.24
24h Volume:
77,898
Relative Volume:
1.23
Market Cap:
$221.13M
Revenue:
$19.85M
Net Income/Loss:
$-12.75M
P/E Ratio:
-14.83
EPS:
-1.38
Net Cash Flow:
$-21.94M
1W Performance:
+2.15%
1M Performance:
+5.30%
6M Performance:
+15.99%
1Y Performance:
-2.06%
1-Day Range:
$20.10
$21.03
1-Week Range:
$19.73
$21.03
52-Week Range:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
20.46 | 216.48M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.81 | 120.40B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.52 | 61.30B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.53 | 41.06B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
564.59 | 34.29B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.55 | 27.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-02-25 | Initiated | Alliance Global Partners | Buy |
| Feb-28-25 | Initiated | Craig Hallum | Buy |
| Jul-16-24 | Reiterated | Maxim Group | Buy |
| Dec-22-22 | Initiated | Maxim Group | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Sep-23-20 | Initiated | BTIG Research | Buy |
| Nov-28-16 | Initiated | Aegis Capital | Buy |
| Aug-17-16 | Initiated | Wells Fargo | Outperform |
| Apr-16-14 | Initiated | Oppenheimer | Outperform |
View All
Mediwound Ltd Stock (MDWD) Latest News
Is MediWound Ltd. a good long term investmentBreakout profit opportunities - PrintWeekIndia
What analysts say about MediWound Ltd. stockRemarkably fast returns - PrintWeekIndia
MediWound Ltd. Stock Analysis and ForecastFree Buy/Sell Signal Notifications - PrintWeekIndia
What drives MediWound Ltd. stock priceRapid wealth creation - jammulinksnews.com
MediWound (NASDAQ:MDWD) Lowered to “Sell” Rating by Wall Street Zen - Defense World
When is the best time to buy MediWound Ltd. stockProven High Yield Signals - Newser
Does MediWound Ltd. stock pay reliable dividends200 Percent Watchlist - Newser
Where are the Opportunities in (MDWD) - news.stocktradersdaily.com
How MediWound Ltd. stock performs during market volatilityFree Investment Community - Newser
Why MediWound Ltd. stock attracts strong analyst attentionPrecision Entry Strategy - Newser
What makes MediWound Ltd. stock price move sharplyFree Stock Market Knowledge Sharing - Newser
MediWound Ltd. (NASDAQ:MDWD) is definitely on the radar of institutional investors who own 42% of the company - Yahoo Finance
Janney Montgomery Scott LLC Has $279,000 Stock Holdings in MediWound Ltd. (NASDAQ:MDWD) - Defense World
MediWound Ltd.(NasdaqGM: MDWD) added to Russell Small Cap Comp Value Index - MarketScreener
Analysts Set MediWound Ltd. (NASDAQ:MDWD) Target Price at $31.80 - Defense World
Bank of America Corp DE Has $141,000 Holdings in MediWound Ltd. (NASDAQ:MDWD) - Defense World
(MDWD) On The My Stocks Page - news.stocktradersdaily.com
Analysts Set MediWound Ltd. (NASDAQ:MDWD) PT at $31.25 - Defense World
When (MDWD) Moves Investors should Listen - news.stocktradersdaily.com
MediWound (NASDAQ:MDWD) Now Covered by Oppenheimer - Defense World
Oppenheimer assumes MediWound stock at outperform, sets $34 PT By Investing.com - Investing.com India
Oppenheimer assumes MediWound stock at outperform, sets $34 PT - Investing.com
Oppenheimer Adjusts MediWound Price Target to $34 From $36, Maintains Outperform Rating - marketscreener.com
MediWound (MDWD) Garners Outperform Rating with Strategic Advanc - GuruFocus
Companies Like MediWound (NASDAQ:MDWD) Are In A Position To Invest In Growth - Yahoo Finance
What is HC Wainwright’s Forecast for MediWound Q2 Earnings? - Defense World
Northern Trust Corp Has $2.58 Million Holdings in MediWound Ltd. (NASDAQ:MDWD) - Defense World
MediWound (NASDAQ:MDWD) PT Set at $31.00 by HC Wainwright - Defense World
H.C. Wainwright lifts MediWound stock target to $31, maintains buy By Investing.com - Investing.com South Africa
H.C. Wainwright lifts MediWound stock target to $31, maintains buy - Investing.com
MDWD: HC Wainwright & Co. Raises Price Target for MediWound | MD - GuruFocus
MediWound (MDWD) Target Price Raised by Analyst | MDWD Stock News - GuruFocus
MediWound (MDWD) Target Price Raised by Analyst | MDWD Stock New - GuruFocus
Mediwound Ltd Stock (MDWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):